Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility study
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
PURPOSE: Accurate assessment of toxicity allows for timely delivery of supportive measures during radiation therapy for head and neck cancer. The current paradigm requires weekly evaluation of patients by a provider. The purpose of this study is to evaluate the feasibility of monitoring patient reported symptoms via mobile devices. METHODS AND MATERIALS: We developed a mobile application for patients to report symptoms in 5 domains using validated questions. Patients were asked to report symptoms using a mobile device once daily during treatment or more often as needed. Clinicians reviewed patient-reported symptoms during weekly symptom management visits and patients completed surveys regarding perceptions of the utility of the mobile application. The primary outcome measure was patient compliance with mobile device reporting. Compliance is defined as number of days with a symptom report divided by number of days on study. RESULTS: There were 921 symptom reports collected from 22 patients during treatment. Median reporting compliance was 71% (interquartile range, 45%-80%). Median number of reports submitted per patient was 34 (interquartile range, 21-53). Median number of reports submitted by patients per week was similar throughout radiation therapy and there was significant reporting during nonclinic hours. Patients reported high satisfaction with the use of mobile devices to report symptoms. CONCLUSIONS: A substantial percentage of patients used mobile devices to continuously report symptoms throughout a course of radiation therapy for head and neck cancer. Future studies should evaluate the impact of mobile device symptom reporting on improving patient outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70910-x · Cited by 653 · cited 1×
“One cross-sectional study examining toxicity reporting showed rates of discordance between clinician and patient reported toxicity ranging between 15% and 59% for various symptoms.(1) Another study of patients enrolled in clinical trials found that patient-reported toxicity was higher than clinician-reported toxicity…”
BackgroundSelf-citationThe Missing Voice of Patients in Drug-Safety Reporting
Basch, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmp0911494 · Cited by 646 · cited 1×
“Another study of patients enrolled in clinical trials found that patient-reported toxicity was higher than clinician-reported toxicity for a variety of endpoints.(2) Some evidence suggests that patient-reported symptoms better correlate with underlying functional status and clinical outcomes than clinician-reported sy…”
BackgroundSelf-citationAhmed, S., Berzon, R. A., Revicki, D. A., Lenderking, W. R., Moinpour, C. M., Basch, E., Reeve, B. B., & Wu, A. W. (2012) · Medical Care · doi:10.1097/mlr.0b013e318268aaff · Cited by 272
Self-citationKearney, N., McCann, L., Norrie, J., Taylor, L., Gray, P., McGee-Lennon, M., Sage, M., Miller, M., & Maguire, R. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0515-0 · Cited by 263 · cited 1×
“Previous studies evaluating mobile device symptom reporting for patients receiving chemotherapy experienced a steady decline in participants contributing data.(8) Similarly, a study demonstrating feasibility of using”
Cited by
Big Data and machine learning in radiation oncology: State of the art and future prospects
Bibault, J.-E., Giraud, P., & Burgun, A. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.033 · Cited by 346
Qudah, B., & Luetsch, K. (2019) · Patient Education and Counseling · doi:10.1016/j.pec.2019.01.021 · Cited by 200
Cho, Y., Zhang, H., Harris, M. R., Gong, Y., Smith, E. L., & Jiang, Y. (2021) · Journal of Medical Internet Research · doi:10.2196/24638 · Cited by 53
“The most commonly reported reasons for patients’ reluctance to participate in e-SRS studies were the lack of access to compatible devices (eg, computers, smartphones, or tablets) [31,46,50,51,53,58]; lack of access to the internet [31,46]; or limited experience with computers, smartphones, or the internet [33,37,53,59…”
BackgroundInfluentialApplication of Information Technology to Clinical Trial Evaluation and Enrollment: A Review
von Itzstein, M. S., Hullings, M., Mayo, H., Beg, M. S., Williams, E. L., & Gerber, D. E. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.1165 · Cited by 36
Metadata
- Authors
- Falchook, A. D., Tracton, G., Stravers, L., Fleming, M. E., Snavely, A. C., Noe, J. F., Hayes, D. N., Grilley-Olson, J. E., Weiss, J. M., Reeve, B. B., Basch, E. M., & Chera, B. S.
- Venue
- Advances in Radiation Oncology
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 1
- Issue
- 2
- Pages
- 115-121
- ISSN
- 2452-1094 (ISSN-L)
- OpenAlex
- W2291172978
- Cited by
- 46
- References
- 4
- FWCI
- 12.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.